(Q47731388)

5 February 2018

title

Both early-onset and late-onset ventilator-associated pneumonia are caused mainly by potentially multiresistant bacteria. (English)

1 reference

5 February 2018

1 reference

multiple drug resistance

1 reference

Elpis Giantsou

1

1 reference

5 February 2018

Nikolaos Liratzopoulos

2

1 reference

5 February 2018

Eleni Efraimidou

3

1 reference

5 February 2018

Maria Panopoulou

4

1 reference

5 February 2018

Eleonora Alepopoulou

5

1 reference

5 February 2018

Sofia Kartali-Ktenidou

6

1 reference

5 February 2018

George I Minopoulos

7

1 reference

5 February 2018

Spyros Zakynthinos

8

1 reference

5 February 2018

Konstantinos I Manolas

9

1 reference

5 February 2018

publication date

7 September 2005

1 reference

5 February 2018

published in

Intensive Care Medicine

1 reference

5 February 2018

volume

31

1 reference

5 February 2018

issue

11

1 reference

5 February 2018

page(s)

1488-1494

1 reference

5 February 2018

https://scigraph.springernature.com/pub.10.1007/s00134-005-2697-y

exact match

0 references

cites work

Ventilator-associated pneumonia caused by potentially drug-resistant bacteria.

1 reference

https://api.crossref.org/works/10.1007%2FS00134-005-2697-Y

Validation of different techniques for the diagnosis of ventilator-associated pneumonia. Comparison with immediate postmortem pulmonary biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-005-2697-Y

Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-005-2697-Y

Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-005-2697-Y

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-005-2697-Y

Variations in etiology of ventilator-associated pneumonia across four treatment sites: implications for antimicrobial prescribing practices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-005-2697-Y

The Value of Routine Microbial Investigation in Ventilator-Associated Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-005-2697-Y

Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-005-2697-Y

Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients

21 January 2018

1 reference

12 December 2020

Nosocomial pneumonia in patients receiving continuous mechanical ventilation. Prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques

1 reference

12 December 2020

Specificity of endotracheal aspiration, protected specimen brush, and bronchoalveolar lavage in mechanically ventilated patients

1 reference

12 December 2020

Treatment with aztreonam or tobramycin in critical care patients with nosocomial gram-negative pneumonia

1 reference

12 December 2020

International Conference for the Development of Consensus on the Diagnosis and Treatment of Ventilator-associated Pneumonia

1 reference

12 December 2020

Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society, November 1995

1 reference

12 December 2020

Pneumonia due to Haemophilus influenzae among mechanically ventilated patients. Incidence, outcome, and risk factors

1 reference

12 December 2020

Therapy for nosocomial pneumonia

1 reference

12 December 2020

Invasive diagnostic testing should be routinely used to manage ventilated patients with suspected pneumonia

1 reference

12 December 2020

The effect of antibiotic therapy on recovery of intracellular bacteria from bronchoalveolar lavage in suspected ventilator-associated nosocomial pneumonia.

1 reference

12 December 2020

Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia

1 reference

12 December 2020

Hospital-acquired pneumonia: coverage and treatment adequacy of current guidelines

1 reference

12 December 2020

Detection of nosocomial lung infection in ventilated patients. Use of a protected specimen brush and quantitative culture techniques in 147 patients

1 reference

12 December 2020

Incidence, etiology, and outcome of nosocomial pneumonia in mechanically ventilated patients

1 reference

12 December 2020

Ceftazidime versus tobramycin/ticarcillin in treating hospital acquired pneumonia and bacteremia

1 reference

12 December 2020

Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia.

1 reference

12 December 2020

Protected Bronchoalveolar Lavage: A New Bronchoscopic Technique to Retrieve Uncontaminated Distal Airway Secretions

1 reference

12 December 2020

A comparative analysis of patients with early-onset vs late-onset nosocomial pneumonia in the ICU setting

1 reference

12 December 2020

Impact of invasive and noninvasive quantitative culture sampling on outcome of ventilator-associated pneumonia: a pilot study

1 reference

12 December 2020

Pneumonia in the critically ill hospitalized patient

1 reference

12 December 2020

Cefoperazone versus combination antibiotic therapy of hospital-acquired pneumonia

1 reference

12 December 2020

The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults

1 reference

12 December 2020

Epidemiology and risk factors of pneumonia in critically ill patients

1 reference

12 December 2020

The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group

1 reference

12 December 2020

Pneumonia in intubated trauma patients. Microbiology and outcomes

1 reference

12 December 2020

10.1007/S00134-005-2697-Y

Identifiers

DOI

1 reference

5 February 2018

PubMed ID

16151723

1 reference

5 February 2018